<DOC>
	<DOCNO>NCT01315418</DOCNO>
	<brief_summary>This multicentric , randomize , double-blind control study aim examine effect ferment dairy product contain probiotic Lactobacillus casei DN-114 001 ( Actimel® = test product ) incidence respiratory gastro-intestinal common infectious disease ( cumulate number infection intervention period : primary criterion ) , Quality Life adult submit multi-stressor situation . Volunteers receive either 200g/day test product ( N=121 ) control product ( N=118 ) 7-weeks .</brief_summary>
	<brief_title>Effect Consumption Fermented Milk Common Infections Adults Submitted Multi-stressor Situation</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Gastroenteritis</mesh_term>
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Pharyngitis</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Nasopharyngitis</mesh_term>
	<criteria>male female age 1829 year attend 7 week firemen train school 19 29 kg/m2 body mass index find medically healthy ( particular , free respiratory GI tract symptom ) agree write informed consent , appreciate dairy product multifruit flavour . Subject read write French , understand inform consent study protocol subject allergy hypersensitivity milk proteins dairy food component ( ex : lactose ) , know food respiratory allergy ; subject presenting severe evolutive chronic pathology ( Ex : cancer , tuberculosis , Crohn disease , cirrhosis , multiple sclerosis , Type I diabetes… ) past actual health condition may interfere outcome study ( Ex : HIV , Chemotherapy , malabsorption , ulcer , celiac disease… ) subject experience infectious disease last 7 day subject current diarrhoea constipation subject frequently use laxative use laxative week prior participation study subject artificial nutrition , gastrointestinal surgery intervention require general anaesthesia last 2 month prior participation study subject special medicate diet ( obesity , anorexia , metabolic pathology , nutritional complementation… ) eat disorder ( anorexia , bulimia , alcoholism… ) subject currently receive , receive last month , systemic treatment topical treatment likely interfere evaluation study parameter : antibiotic , antiseptic , antifungal , corticoid , vaccine , antihistaminic molecule , noncorticoid antiinflammatory substance , immunosuppressant treatment… subject already enrol another clinical study , currently exemption period previous study female subject currently pregnant breastfeeding , willing become pregnant 2 coming month enrolment study subject situation investigator 's opinion could interfere optimal participation present study could constitute special risk subject</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>29 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Probiotic - Lactobacillus casei DN-114 001 - dairy product -</keyword>
	<keyword>infection - fireman</keyword>
	<keyword>Common infectious disease , occur healthy subject ,</keyword>
	<keyword>include upper respiratory tract infection ( define</keyword>
	<keyword>rhinopharyngitis , sore throat , sinusitis otitis )</keyword>
	<keyword>low respiratory tract infection ( define bronchitis</keyword>
	<keyword>pneumopathy flu flu-like syndrome )</keyword>
	<keyword>gastrointestinal tract infection define gastroenteritis</keyword>
</DOC>